Batson S C, Sundseth R, Heath C V, Samuels M, Hansen U
Laboratory of Eukaryotic Transcription, Dana-Farber Cancer Institute, Boston, Massachusetts 02115.
Mol Cell Biol. 1992 Apr;12(4):1639-51. doi: 10.1128/mcb.12.4.1639-1651.1992.
We have studied the initiation of transcription in vitro by RNA polymerase II on simian virus 40 (SV40) minichromosomal templates isolated from infected cells. The efficiency and pattern of transcription from the chromatin templates were compared with those from viral DNA templates by using two in vitro transcription systems, either HeLa whole-cell extract or basal transcription factors, RNA polymerase II, and one of two SV40 promoter-binding transcription factors, LSF and Sp1. Dramatic increases in numbers of transcripts upon addition of transcription extract and different patterns of usage of the multiple SV40 initiation sites upon addition of Sp1 versus LSF strongly suggested that transcripts were being initiated from the minichromosomal templates in vitro. That the majority of transcripts from the minichromosomes were due to initiation de novo was demonstrated by the efficient transcription observed in the presence of alpha-amanitin, which inhibited minichromosome-associated RNA polymerase II, and an alpha-amanitin-resistant RNA polymerase II, which initiated transcription in vitro. The pattern of transcription from the SV40 late and early promoters on the minichromosomal templates was similar to the in vivo pattern of transcription during the late stages of viral infection and was distinct from the pattern of transcription generated from viral DNA in vitro. In particular, the late promoter of the minichromosomal templates was transcribed with high efficiency, similar to viral DNA templates, while the early-early promoter of the minichromosomal templates was inhibited 10- to 15-fold. Finally, the number of minichromosomes competent to initiate transcription in vitro exceeded the amount actively being transcribed in vivo.
我们研究了从感染细胞中分离出的猿猴病毒40(SV40)微型染色体模板上,RNA聚合酶II在体外启动转录的情况。通过使用两种体外转录系统,即HeLa全细胞提取物或基础转录因子、RNA聚合酶II以及两种SV40启动子结合转录因子LSF和Sp1之一,将染色质模板的转录效率和模式与病毒DNA模板的进行了比较。添加转录提取物后转录本数量急剧增加,以及添加Sp1与LSF后多个SV40起始位点的不同使用模式,强烈表明转录本是在体外从微型染色体模板上起始的。在存在抑制微型染色体相关RNA聚合酶II的α-鹅膏蕈碱和一种在体外启动转录的α-鹅膏蕈碱抗性RNA聚合酶II的情况下观察到的有效转录,证明了微型染色体的大多数转录本是由于从头起始。微型染色体模板上SV40晚期和早期启动子的转录模式与病毒感染后期的体内转录模式相似,并且与体外从病毒DNA产生的转录模式不同。特别是,微型染色体模板的晚期启动子转录效率很高,类似于病毒DNA模板,而微型染色体模板的极早期启动子受到10至15倍的抑制。最后,在体外能够启动转录的微型染色体数量超过了体内正在活跃转录的数量。